An inflammatory polymorphisms risk scoring system for the differentiation of ischemic stroke subtypes

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Muiño, Elena ^a   Krupinski, Jurek ^a   Carrera, Caty ^b   Gallego Fabrega, Cristina ^a   Montaner, Joan ^b   Fernández Cadenas, Israel ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENETIC SCORING SYSTEM; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION; CEREBROVASCULAR ACCIDENT; CLASSIFICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; ODDS RATIO; RISK FACTOR;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 84940827552     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/569714     Document Type: Article

References (22)

1. D. Lloyd-Jones, R. Adams, M. Carnethon et al., "Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee," Circulation, vol. 119, no. 3, pp. e21-e181, 2009.
2. S. Domingues-Montanari, M. Mendioroz, A. del Rio-Espinola, I. Fernandez-Cadenas, and J. Montaner, "Genetics of stroke: a review of recent advances," Expert Review of Molecular Diagnostics, vol. 8, no. 4, pp. 495-513, 2008.
3. S. Domingues-Montanari, I. Fernandez-Cadenas, A. Del Rio-Espinola et al., "Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study," Cerebrovascular Diseases, vol. 29, no. 6, pp. 528-537, 2010.
4. S. Bevan, M. Traylor, P. Adib-Samii et al., "Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations," Stroke, vol. 43, no. 12, pp. 3161-3167, 2012.
5. S. Kathiresan, O. Melander, D. Anevski et al., "Polymorphisms associated with cholesterol and risk of cardiovascular events," The New England Journal ofMedicine, vol. 358, no. 12, pp. 1240-1249, 2008.
6. E. J. Benjamin, K. M. Rice, D. E. Arking et al., "Variants in ZFHX3 are associated with a trial fibrillation in individuals of European ancestry," Nature Genetics, vol. 41, no. 8, pp. 879-881, 2009.
7. D. F. Gudbjartsson, H. Holm, S. Gretarsdottir et al., "A sequence variant in ZFHX3 on 16q22 associates with a trial fibrillation and ischemic stroke," Nature Genetics, vol. 41, no. 8, pp. 876-878, 2009.
8. S. Gretarsdottir, G. Thorleifsson, A. Manolescu et al., "Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke," Annals of Neurology, vol. 64, no. 4, pp. 402-409, 2008.
9. A. Gschwendtner, S. Bevan, J. W. Cole et al., "Sequence variants on chromosome 9p21. 3 confer risk for atherosclerotic stroke," Annals of Neurology, vol. 65, no. 5, pp. 531-539, 2009.
10. C. Bellenguez, S. Bevan, A. Gschwendtner et al., "Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke," Nature Genetics, vol. 44, no. 3, pp. 328-333, 2012.
11. M. Traylor, M. Farrall, E. G. Holliday et al., "Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies," The Lancet Neurology, vol. 11, no. 11, pp. 951-962, 2012.
12. F. Carbone, F. Mach, and F. Montecucco, "Update on the role of neutrophils in atherosclerotic plaque vulnerability," Current Drug Targets, vol. 16, no. 4, pp. 321-333, 2015.
13. H. Xu, Y. Tang, D.-Z. Liu et al., "Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke," Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 7, pp. 1320-1328, 2008.
14. A. Del Rio-Espinola, I. Fernandez-Cadenas, D. Giralt et al., "A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke," Annals of Neurology, vol. 72, no. 5, pp. 716-729, 2012.
15. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., "Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment," Stroke, vol. 24, no. 1, pp. 35-41, 1993.
16. C. J. Boos, R. A. Anderson, and G. Y. H. Lip, "Is atrialfibrillation an inflammatory disorder?" European Heart Journal, vol. 27, no. 2, pp. 136-149, 2006.
17. H.-H. Chen and D. L. Wang, "Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells," Molecular Pharmacology, vol. 65, no. 5, pp. 1130-1140, 2004.
18. T. Matsunaga, D. W. Weihrauch, M. C. Moniz, J. Tessmer, D. C. Warltier, and W. M. Chilian, "Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide," Circulation, vol. 105, no. 18, pp. 2185-2191, 2002.
19. W. Eberhardt, T. Beeg, K.-F. Beck et al., "Nitric oxide modulates expression ofmatrixmetalloproteinase-9 in ratmesangial cells," Kidney International, vol. 57, no. 1, pp. 59-69, 2000.
20. I. Fernandez-Cadenas, M. Mendioroz, S. Domingues-Montanari et al., "Leukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patients," European Journal of Neurology, vol. 18, no. 6, pp. 826-835, 2011.
21. A. Terruzzi, L. Valente, R. Mariani, L. Moschini, and M. Camerlingo, "C-reactive protein and aetiological subtypes of cerebral infarction," Neurological Sciences, vol. 29, no. 4, pp. 245-249, 2008.
22. T. Kuwashiro, H. Sugimori, T. Ago, J. Kuroda, M. Kamouchi, and T. Kitazono, "Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry," BMJ Open, vol. 3, no. 11, article 4, 2013.